Aratana Therapeutics Inc  

(Public, NASDAQ:PETX)   Watch this stock  
Find more results for Wendy L. Yarno
13.96
+0.42 (3.10%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 13.21 - 14.20
52 week 6.56 - 29.32
Open 13.51
Vol / Avg. 131,025.00/311,253.00
Mkt cap 411.50M
P/E     -
Div/yield     -
EPS -0.37
Shares 29.48M
Beta     -
Inst. own 51%
Mar 13, 2014
Q4 2013 Aratana Therapeutics Inc Earnings Release
Mar 13, 2014
Q4 2013 Aratana Therapeutics Inc Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 5786.18% -3485.37%
Operating margin -6613.82% -16148.78%
EBITD margin - -15826.83%
Return on average assets 33.94% -6.27%
Return on average equity 43.96% -13.30%
Employees 41 -
CDP Score - -

Address

1901 OLATHE BOULEVARD
KANSAS CITY, KS 66103
United States - Map
+1-913-9512130 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aratana Therapeutics, Inc. is a development-stage biopharmaceutical company. As of March 20, 2013, the Company has three licensed compounds in development for six product approvals in cats and dogs in each of the United States and Europe. In January 2014, the Company announced that it has acquired Okapi Sciences NV, a Belgium-based company with a pet therapeutics antiviral platform and five clinical/development-stage candidates for treating important viral diseases.

Officers and directors

Jay Lichter Ph.D. Chairman of the Board
Age: 51
Bio & Compensation  - Reuters
Steven St. Peter M.D President, Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Craig A. Tooman Chief Financial Officer, Treasurer
Age: 48
Bio & Compensation  - Reuters
Linda Rhodes Ph.D. Chief Scientific Officer
Age: 64
Bio & Compensation  - Reuters
Ernst Heinen Ph.D. Head - Drug Evaluation and Development
Age: 51
Bio & Compensation  - Reuters
Julia A. Stephanus Chief Commercial Officer
Age: 55
Bio & Compensation  - Reuters
Laura A. Brege Director
Age: 55
Bio & Compensation  - Reuters
David L. Brinkley Director
Age: 55
Bio & Compensation  - Reuters
Merilee Raines Director
Age: 57
Bio & Compensation  - Reuters
Wendy L. Yarno Director
Age: 59
Bio & Compensation  - Reuters